166649

166649
Send Message
  • 166649
    $IDTI Cramer's Stop Trading: Don't give up on IDTI 1 Hour Ago http://cnb.cx/1nDm7w5
    Feb 2, 11:38 AM
    Reply
      • 166649
        $CYBR good day, and follow through too...double bottom day today. Nice push up from there
        12/8/15
        Reply (1)
        • rasputinboy: hope so -my calls are ticking away
          12/8/15
          • 166649
            $CYBR Jim Cramer Picks 3 Companies to Be Acquired or Go Private in 2016 http://bit.ly/1Nv88Cr
            12/4/15
            Reply (6)
          • View all 6 replies
            • matratra: Any third grader would pick MSFT or CSCO & let alone Cramer. He doesn't serve credit for it
              12/4/15
            • D-struction: agreed
              12/4/15
              • 166649
                $CYBR 'Warren Buffett Is Satisfied With $IBM, but Jim Cramer Wants More' 12/1/2015 video http://bit.ly/1YLkZE1
                12/3/15
                Reply
                  • 166649
                    $QURE Oppenheimer $50 price target and Outperform rating on the shares.
                    12/1/15
                    Reply
                      • 166649
                        $QURE WallachBeth raises their QURE tgt to $60 from $33 noting Hemophilia B top-line data expected in 1Q16
                        12/1/15
                        Reply
                          • 166649
                            $FIT Barclays upgrade details- fastest-growing meaningful consumer Co. in world 140%+ rev y/y in 2015 in a world lacking true growth stories
                            11/30/15
                            Reply
                              • 166649
                                $FIT Stifel Buy Tgt $60 retailers prominently featuring FIT's products, consumers are responding strongly can beat expectations by large amt
                                11/30/15
                                Reply
                                  • 166649
                                    $AFSI FBR Buy $76 tgt adj est. conservative given upside to fee income and premium growth that can be achieved profitable growth established
                                    11/18/15
                                    Reply
                                      • 166649
                                        $RDUS on Cramer's Mad Money http://bit.ly/1YgbQDs Cramer said today's big decline represents a buying opportunity for RDUS
                                        11/18/15
                                        Reply
                                          • 166649
                                            $AFSI Amtrust Financial upgraded to Buy at Compass Point; tgt $70
                                            11/13/15
                                            Reply
                                              • 166649
                                                $PAYC raised to $55 from $48 at Jefferies analyst DiFucci says "increasing momentum and is exceeding estimates across all metrics buyTgt $55
                                                11/11/15
                                                Reply
                                                  • 166649
                                                    $NVLS Drug that works in tandem w/N91115 from VRTX Orkambi got FDA approval 7/2 fast start 3000 peop under treatment/ rev $130.8 M in 3Q
                                                    11/6/15
                                                    Reply
                                                      • 166649
                                                        $NVLS 10/7 remains on track to enroll first patient in Phase 2 study this Q an continues to expect data from study to be available in 2H16.
                                                        11/6/15
                                                        Reply
                                                          • 166649
                                                            $NVLS has the rare potential for high double digit or triple digit upside if data due in 2H16 shows good performance for N91115
                                                            11/6/15
                                                            Reply
                                                              • 166649
                                                                $NVLS released positive safety results in its Phase 1b trial for its primary drug candidate N91115 on October 7
                                                                11/6/15
                                                                Reply
                                                                  • 166649
                                                                    $NVLS The average price target for NVLS is $27.33, or, 230% higher than NVLS' current price-- Stifel $23 Baird $29 Wainwright $30
                                                                    11/5/15
                                                                    Reply
                                                                      • 166649
                                                                        $LGIH Short Float 21.55% Next earnings release 11/4 bm confirmed, EPS Cap 1 consensus .73 rev consensus 169.87mln
                                                                        11/2/15
                                                                        Reply
                                                                          • 166649
                                                                            $LGIH impressive increase in guide last Q. co. now expects 2/15 EPS of $2.15-2.50 vs prior guide of $1.85-2.25 points to very strong 2H15
                                                                            11/2/15
                                                                            Reply
                                                                              • 166649
                                                                                $IDTI (Just now at 10:21 EDT) price target raised to $33 from $25 at Dougherty :-)
                                                                                10/27/15
                                                                                Reply